Beta-adrenergic Blockade in Hypertrophic Obstructive Cardiomyopathy

46Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

This paper deals with our experience with beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathy investigated at the Hammersmith Hospital and Post-graduate Medical School. Acute studies showed little or no effect on resting gradients. Beta-adrenergic blockade was, however, effective in decreasing or abolishing the increase in outflow gradient resulting from exercise or isoprenaline infusion. Long-term studies in 13 patients showed subjective improvement in 10. Objective signs did not always parallel the improvement, though there was often a decrease in the intensity of the murmur due to an increase in heart size. This is a preliminary report, and suggests that beta-adrenergic blockade may be of value in the long-term management of patients with hypertrophic obstructive cardiomyopathy. Longer studies in a larger group of patients are indicated before any firm conclusions can be drawn. A warning note is sounded concerning the importance of establishing a firm diagnosis before embarking on treatment. © 1966, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Cherian, G., Brockington, I. F., Shah, P. M., Oakley, C. M., & Goodwin, J. F. (1966). Beta-adrenergic Blockade in Hypertrophic Obstructive Cardiomyopathy. British Medical Journal, 1(5492), 895–898. https://doi.org/10.1136/bmj.1.5492.895

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free